OLIVIA MURATIDES: Open Payments
NPI 1174092498 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 72 payments from 11 companies in 2025. Trend: 2023 $1,606 · 2024 $1,238 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $477 |
| SK Life Science, Inc. | 13 | $319 |
| UCB, Inc. | 10 | $256 |
| SI-BONE, INC. | 1 | $133 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| ARGENX US, INC. | 1 | $73 |
| HARMONY BIOSCIENCES LLC | 1 | $46 |
| Lilly USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: QULIPTA, Nayzilam, Qelbree, AUSTEDO XR, UBRELVY, Briviact, BOTOX, VYVGART.
Industry payments across FL — which companies pay providers there.
